drugset / Trial / NCT01254045
Double-blind Placebo Controlled Study of Oxytocin in Fragile X Syndrome
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether the medication oxytocin is an effective and tolerable treatment in adolescent males with fragile X syndrome (FraX) for improving socially appropriate behaviors and reducing social anxiety.
Timeline
- Start
- 2007-02
- Primary completion
- 2009-11
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxytocin | Peptide | 24 iu | Intranasal |
| Subject | Oxytocin | Peptide | 48 iu | Intranasal |